Belperio JA - Search Results

1

Pathologic findings in lung allografts with anti-HLA antibodies.

DeNicola MM, Weigt SS, Belperio JA, Reed EF, Ross DJ, Wallace WD. DeNicola MM, et al. Among authors: belperio ja. J Heart Lung Transplant. 2013 Mar;32(3):326-32. doi: 10.1016/j.healun.2012.11.018. Epub 2013 Jan 10. J Heart Lung Transplant. 2013. PMID: 23313559 Free PMC article.

2

Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome.

Belperio JA, Keane MP, Burdick MD, Lynch JP 3rd, Xue YY, Berlin A, Ross DJ, Kunkel SL, Charo IF, Strieter RM. Belperio JA, et al. J Clin Invest. 2001 Aug;108(4):547-56. doi: 10.1172/JCI12214. J Clin Invest. 2001. PMID: 11518728 Free PMC article.

3

Interleukin-1 receptor antagonist as a biomarker for bronchiolitis obliterans syndrome in lung transplant recipients.

Belperio JA, DiGiovine B, Keane MP, Burdick MD, Ying Xue Y, Ross DJ, Lynch JP 3rd, Kunkel SL, Strieter RM. Belperio JA, et al. Transplantation. 2002 Feb 27;73(4):591-9. doi: 10.1097/00007890-200202270-00020. Transplantation. 2002. PMID: 11889437

4

Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome.

Belperio JA, Keane MP, Burdick MD, Lynch JP 3rd, Xue YY, Li K, Ross DJ, Strieter RM. Belperio JA, et al. J Immunol. 2002 Jul 15;169(2):1037-49. doi: 10.4049/jimmunol.169.2.1037. J Immunol. 2002. PMID: 12097412

5

Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection.

Belperio JA, Keane MP, Burdick MD, Lynch JP 3rd, Zisman DA, Xue YY, Li K, Ardehali A, Ross DJ, Strieter RM. Belperio JA, et al. J Immunol. 2003 Nov 1;171(9):4844-52. doi: 10.4049/jimmunol.171.9.4844. J Immunol. 2003. PMID: 14568964

6

Increased bronchoalveolar lavage human beta-defensin type 2 in bronchiolitis obliterans syndrome after lung transplantation.

Ross DJ, Cole AM, Yoshioka D, Park AK, Belperio JA, Laks H, Strieter RM, Lynch JP 3rd, Kubak B, Ardehali A, Ganz T. Ross DJ, et al. Among authors: belperio ja. Transplantation. 2004 Oct 27;78(8):1222-4. doi: 10.1097/01.tp.0000137265.18491.75. Transplantation. 2004. PMID: 15502724

7

Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome.

Belperio JA, Keane MP, Burdick MD, Gomperts B, Xue YY, Hong K, Mestas J, Ardehali A, Mehrad B, Saggar R, Lynch JP, Ross DJ, Strieter RM. Belperio JA, et al. J Clin Invest. 2005 May;115(5):1150-62. doi: 10.1172/JCI24233. J Clin Invest. 2005. PMID: 15864347 Free PMC article.

8

CXCR2/CXCR2 ligand biology during lung transplant ischemia-reperfusion injury.

Belperio JA, Keane MP, Burdick MD, Gomperts BN, Xue YY, Hong K, Mestas J, Zisman D, Ardehali A, Saggar R, Lynch JP 3rd, Ross DJ, Strieter RM. Belperio JA, et al. J Immunol. 2005 Nov 15;175(10):6931-9. doi: 10.4049/jimmunol.175.10.6931. J Immunol. 2005. PMID: 16272353

9

Overview of lung transplantation and criteria for selection of candidates.

Lynch JP 3rd, Saggar R, Weigt SS, Ross DJ, Belperio JA. Lynch JP 3rd, et al. Among authors: belperio ja. Semin Respir Crit Care Med. 2006 Oct;27(5):441-69. doi: 10.1055/s-2006-954604. Semin Respir Crit Care Med. 2006. PMID: 17072794 Review.

10

IL-13 is pivotal in the fibro-obliterative process of bronchiolitis obliterans syndrome.

Keane MP, Gomperts BN, Weigt S, Xue YY, Burdick MD, Nakamura H, Zisman DA, Ardehali A, Saggar R, Lynch JP 3rd, Hogaboam C, Kunkel SL, Lukacs NW, Ross DJ, Grusby MJ, Strieter RM, Belperio JA. Keane MP, et al. Among authors: belperio ja. J Immunol. 2007 Jan 1;178(1):511-9. doi: 10.4049/jimmunol.178.1.511. J Immunol. 2007. PMID: 17182591

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

224 results

Search Page